-
Hyperactive abroad, Emmanuel Macron is struggling at home
The French president is once more running into problems over pension reform
-
Bayer shifts pharma focus away from ‘innovation unfriendly’ Europe
German group’s drugs chief warns EU and UK are dissuading investment as company prioritises US
-
US drugmakers withdraw from NHS pricing agreement as costs soar
AbbVie and Eli Lilly take action after levy on branded drugs reaches a quarter of
-
Microsoft’s $10bn bet on ChatGPT developer marks new era of AI
Tech giants race to stake out their place in new field of generative artificial intelligence
-
German defence minister resigns after series of gaffes
Christine Lambrecht’s exit comes at a delicate moment for Berlin as it considers sending tanks
-
Turkey seeks to reassure allies on Nato enlargement
Defence minister Hulusi Akar backs expansion and defends criticism of his country’s role in the
-
European stocks tick up as investors shrug off central bank warnings
Rate-setters argue core inflation remains too high to justify cutting interest rates soon
-
Downbeat in Davos as Europe confronts an end to peace and prosperity
Also in today’s newsletter: scandal-hit European parliament returns to work with its reputation on the




